文献速递冠心病

重复血运重建作为终点指标的局限性:JACC综述

Limitations of Repeat Revascularization as an Outcome Measure: JACC Review Topic of the Week.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

该综述聚焦于比较经皮冠状动脉介入治疗与冠状动脉旁路移植术的试验中常用的终点指标——重复血运重建,指出其存在适应证混杂、移植物与支架失败后血运重建概率不同、预后意义不确定及患者偏好影响等局限性,并给出将该指标用作终点的使用与评估建议。

要点

  • 重复血运重建受应激试验使用和造影阈值影响,存在适应证混杂。
  • 移植物失败与支架失败后再次血运重建的可能性不同,影响比较。
  • 解读以重复血运重建为主要终点的PCI与CABG对比试验需谨慎。

核心结论

  • 重复血运重建作为终点指标存在重要局限性,理解这些问题有助于更好评价其作为临床有意义终点的价值。

研究设计与样本

  • JACC综述,检索范围与纳入研究数量原文未报告。

主要发现

  • 重复血运重建是PCI与CABG对比试验常用终点,其差异常驱动主要终点的相对风险。
  • 局限性包括适应证混杂、移植物与支架失败后血运重建概率不同、重复血运重建预后影响不确定及患者偏好。

临床怎么用

  • 在比较不同血运重建方式的试验中,应结合本文建议谨慎使用和评估重复血运重建终点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Repeat revascularization is a commonly used outcome measure in trials comparing percutaneous coronary intervention and coronary artery bypass graft surgery, and differences in this outcome often drive the relative risk for the primary endpoint. However, repeat revascularization as an outcome measure has important limitations that complicates its meaningful interpretation, including confounding by indication (driven by varying use of stress testing and thresholds for invasive angiography), differential likelihood of revascularization after graft versus stent failure, uncertainty of the prognostic impact of repeat revascularization, and patient preferences and appraisal of the import of repeat revascularization. Knowledge of these issues will result in better appreciation of the utility of repeat revascularization as a clinically meaningful outcome measure. The authors describe these issues and provide recommendations for the use and assessment of repeat revascularization as an endpoint when comparing different revascularization modalities.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Lamelas P, Belardi J, Whitlock R, et al. Limitations of Repeat Revascularization as an Outcome Measure: JACC Review Topic of the Week. J Am Coll Cardiol. 2019. PMID: 31856974. doi:10.1016/j.jacc.2019.10.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。